Johannes Gerardus Christiaan Petrus Schikan Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 2 days, 14 hours ago
Johannes Gerardus Christiaan Petrus Schikan has an estimated net worth of at least $13.2 million*, as of Oct. 21, 2026. They own 115,967 shares of PHVS stock. They have sold 280,800 shares of PHVS stock since 2021, for an estimated $9.7 million.
Johannes Gerardus Christiaan Petrus Schikan $PHVS SEC Form 4 Insider Trading
Johannes Gerardus Christiaan Petrus Schikan has filed a total of 10 insider trades in $PHVS since 2021. Their most recent trade was a sale of 800 shares, made on Sep 22, 2026. Their largest trade was a sale of 200,000 shares, made on Sep 17, 2026. We estimate that they now own 115,967 shares of $PHVS, worth an estimated $3.6 million.
Insider Trading at $PHVS
There have been a total of 71 insider trades reported at $PHVS since 2021, with 0 shares purchased and 954,189 shares sold. The most active insider traders in $PHVS stock have been Anne Lesage, Peng Lu, and Berndt Modig. The most recent trade was a sale of 800 shares reported by Johannes Gerardus Christiaan Petrus Schikan (None), made on Sep 22, 2026.
History of Insider Stock Trades by Johannes Gerardus Christiaan Petrus Schikan
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
PHVS
|
Sale | 800 | Sep 22, 2026 | Sept. 25, 2026, 6:03 p.m. |
PHVS
|
Sale | 200,000 | Sep 17, 2026 | Sept. 21, 2026, 4:18 p.m. |
PHVS
|
Sale | 6,888 | Jun 29, 2026 | July 1, 2026, 7:06 p.m. |
PHVS
|
Sale | 30,712 | Jun 30, 2026 | July 1, 2026, 7:06 p.m. |
PHVS
|
Sale | 2,400 | Jun 29, 2026 | June 29, 2026, 6:18 p.m. |
PHVS
|
Sale | 670 | Apr 30, 2026 | May 1, 2026, 7:32 p.m. |
PHVS
|
Sale | 28,400 | Apr 30, 2026 | May 1, 2026, 7:32 p.m. |
PHVS
|
Sale | 3,830 | Apr 29, 2026 | May 1, 2026, 7:32 p.m. |
PHVS
|
Sale | 7,000 | Apr 22, 2026 | April 24, 2026, 2:09 p.m. |
PHVS
|
Sale | 100 | Apr 23, 2026 | April 24, 2026, 2:09 p.m. |
$PHVS Executives and Stock Owners with Insider Trades
-
Anne Lesage, Chief Early Development
-
Peng Lu, Chief Medical Officer
-
Berndt Modig, Chief Executive Officer
-
Anna Nijdam, Principal Accounting Officer
-
Peng Lu, President
-
Stefan Andreas Abele, Chief Technical Ops Officer
-
Wim Souverijns, Chief Commercial Officer
-
David W. Nassif, CFO / CLO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.